StocksMedium•11 November 2026•
1 min read
Riskified and Sonoma Pharmaceuticals Shares Surge on Quarterly Earnings Results
Key Facts
1Sonoma Pharmaceuticals stock increased by 13.2% to $1.29 following the release of its Q2 earnings.
2Riskified stock rose 24.6% to $10.57 during Wednesday's pre-market session following its Q3 earnings release.
Riskified stock rose 24.6% to $10.57 during Wednesday's pre-market session following its Q3 earnings release. Benzinga reported that Sonoma Pharmaceuticals stock also increased by 13.2% to $1.29 following the release of its Q2 earnings.
Riskified closed at $8.48 on November 10, 2026, prior to the surge, while Sonoma Pharmaceuticals had a last close of $1.14 on the same date. These price movements indicate a positive market reception to the quarterly financial results of both the technology and healthcare firms.